RNS Number : 8674N ConvaTec Group PLC 11 May 2018
CONVATEC GROUP PLC - AGM
11 MAY 2018 - CORRECTED POLL RESULT
Result of Meeting
ConvaTec Group Plc ("ConvaTec"), a leading global medical products and technologies company, held its annual general meeting today. The results of the poll held in relation to the resolutions proposed at the meeting are set out below. The number of votes withheld has been corrected and a column of number of votes cast included.
1 Receive Annual Report and Accounts
2 Approve the Directors' Remuneration Report
3 Declare Final Dividend
4 Re-elect Sir Christopher Gent as a Director
5 Re-elect Paul Moraviec as a Director
6 Elect Frank Schulkes as a Director
7 Re-elect Steve Holliday as a Director
8 Re-elect Jesper Ovesen as a Director
9 Re-elect Rick Anderson as a Director
10 Re-elect Kasim Kutay as a Director
11 Elect Ros Rivaz as a Director
12 Elect Regina Benjamin as a Director
13 Elect Margaret Ew ing as a Director
14 Re-appoint Deloitte LLP as auditors
15 Authorise the Directors to agree the auditors'
1,483,108,674
1,488,939,928
1,481,688,827
1,482,717,535
1,476,891,196
1,488,985,560
1,488,564,111
1,486,522,754
remuneration
16 Authorise allotment of shares
1,479,661,716
99.25 11,131,674 0.75
633,119
1,490,793,390
76.38%
17 Disapply pre-emption rights*
18 Disapply pre-emption rights in connection w ith an acquisition or specified capital investment*
19 Authorise purchase of ow n shares*
1,485,284,913
99.75
3,698,352
0.25 2,443,243 1,488,983,265
76.29%
20 Authorise political donations and political expenditure
21 Call general meetings on 14 days' notice*
*Special Resolution
NOTES:
1. All resolutions were passed.
2. Votes "For" and "Against" are expressed as a percentage of votes received.
3. A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.
4. Total number of shares in issue at 6.30pm on 8 May 2018 was 1,951,850,599 shares. Up to 76.39% of voting capital was instructed.
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.www.convatecgroup.com
This information is provided by RNS
The company news service from the London Stock Exchange
Enquiries | |
Analysts and Investors | |
John Crosse, VP Investor Relations | +44 (0)7500 141 435 |
Kirsty Law, Director Investor Relations | +44 (0)7470 909 582 |
investorrelations@convatec.com | |
Media | |
Bobby Leach, VP Group Corporate Affairs | +44 (0)7770 842 226 |
Finsbury | +44 (0)207 251 3801 |
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
###
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMSFDFLFFASEEI
Attachments
- Original document
- Permalink
Disclaimer
ConvaTec Group plc published this content on 11 May 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 11 May 2018 14:37:01 UTC